Are you a journalist?

Learn to know ALK

If you have any queries please feel free to contact Media Relations at ALK headquarters or one of our global offices.

The press releases in this press room contains information that is of general news value for the press, and available for journalists or media with a view to journalistic assessment and preparation before publication.

News

  • Post date
    01/08/2026
    ALK to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
  • Post date
    12/22/2025
    ALK – Financial calendar for the 2026 financial year
  • Post date
    12/19/2025
    Major shareholder announcement
  • Post date
    12/01/2025
    ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America
  • Post date
    11/12/2025
    ALK upgrades its full-year outlook
  • Post date
    11/12/2025
    Nine-month interim report (Q3) 2025 (unaudited)
  • Post date
    11/06/2025
    Invitation to the presentation of ALK’s first nine months (Q3) 2025 results on Thursday, 13 November 2025
  • Post date
    09/17/2025
    ALK and GenSci partner to expand the AIT market in China
  • Post date
    09/08/2025
    Real-world evidence supports clinical effectiveness of the neffy® nasal adrenaline spray

Media Relations

Per Plotnikof
Vice President,
Corporate Communications,
Investor Relations and Strategic Planning
Phone: +45 22612525
Email: PPIDK@alk.net

Jeppe Ilkjær
Media Relations Manager
Corporate Communications
Phone: +45 30502014
Email: Jeppe.Ilkjaer@alk.net

Journalists are always welcome to contact ALK’s Media Relations team.
Steen Riisgaard, CEO
Production facilities, Hørsholm
Image
alk_produktion6_0
Production facilities, Hørsholm
Image
alk_produktion3_1
Production facilities, Hørsholm
Image
alk_produktion5
Production facilities, Hørsholm
Image
Family_website_0
ALK HQ, Hørsholm
Last updated: 2016.11.14